All News

2068 articles, sorted by publication time.

Biotechnology and Pharmaceuticals · global

New Lung Cancer Drug’s Survival Curve Continues to Shift in a Favorable Direction, but Key Statistics Remain Undisclosed

The hazard ratio for death fell to 0.76 with ivonescimab plus chemotherapy in a global Phase 3 trial of EGFR-mutant lung cancer, with consistent trends among Eastern and Western patients. However, the updated confidence interval and median survival have not yet been disclosed, and whether this update can change the regulatory assessment will still depend on the complete data.

Cancer Research · us

Keeping Tumors Outside the Body for Drug Testing: Organoid Research Expands the Candidate Pool for Precision Cancer Therapy

Two studies bring miniature models of patients’ tumors closer to serving as repeatedly testable treatment surrogates: one spans 15 cancer types, while the other brings lung cancer and immune cells together in the same experimental system, also revealing that current treatment criteria may overlook some potential beneficiaries.

Biomedical AI · us

Beyond Blast Counts: AI Identifies Blood Cancer Activity From the Spatial Organization of Bone Marrow

A research team condensed the locations, morphology, and neighborhood relationships of more than 5 million cells in bone marrow sections into a single score that preliminarily distinguished active myelodysplastic neoplasms from remission; however, the method still requires validation across hospitals and in large populations and cannot yet replace current diagnostic approaches.

Biomedical Research · eu

Cutting Off Bacteria’s Vitamin Supply: Novel Antibiotic Candidates Advance into Animal Infection Models

The research team targeted ECF transporters, which existing antibiotics have not exploited, preventing bacteria from obtaining the vitamins they need to survive. The candidate compounds have shown activity in multiple infection models, but drug distribution, safety, and resistance assessments still stand between them and use in humans.

Neuroscience · asia

Nanocages That Loosen Amyloid Plaques: Improved Cognition in Alzheimer’s Mice, but Human Treatment Remains a Long Way Off

Using computational design, the research team created a protein–gold nanostructure that recognizes and breaks down aggregated amyloid proteins in mice with familial Alzheimer’s disease; the findings advance the prospect of using precision materials for brain treatment while leaving key questions about distribution, toxicity, and long-term benefits unresolved.

Regenerative Medicine · asia

Delivering Neural Progenitor Cells Into the Injured Spinal Cord: First-in-Human Trial Clears Initial Safety Threshold

Four patients with complete cervical spinal cord injuries showed no tumors or serious graft-related events during two to four years of follow-up after transplantation of iPSC-derived neural cells; two had marked improvements in neurological function grade, but this small, uncontrolled trial cannot yet demonstrate efficacy.

Biopharmaceuticals · us

How Two Single-Patient Trials Are Charting a Clinical Path for a Rare Genetic Disease

Precision antisense drugs targeting SCN2A have delivered more than reduced seizure frequency; from identifying the disease-causing copy and administering repeated intrathecal doses to tracking multiple dimensions of function, the treatment experiences of two children also reveal how a “one drug for one patient” approach can undergo scientific and regulatory scrutiny.

Biopharmaceuticals · global

An Alternative Immune Target in Multiple Myeloma: Early Cevostamab Trial Shows Durable Remissions in Some Patients

This bispecific antibody bypasses the commonly targeted BCMA and produced responses in about four in ten patients who had undergone multiple lines of therapy. Efficacy could be maintained after a limited treatment course, but infections, serious adverse events, and the early-stage trial design also set clear boundaries on the findings.